Blocking Purine Biosynthesis to Fight Tuberculosis
Tuberculosis (TB) remains a formidable global health challenge, complicated by rising drug resistance and the long, complex regimens currently required...
Louis Brooks is a Scienmag editorial specialist profile for Medicinal Chemistry coverage.
Tuberculosis (TB) remains a formidable global health challenge, complicated by rising drug resistance and the long, complex regimens currently required...
Cambridge, MA — In an impressive demonstration of investor confidence and technological promise, Insilico Medicine, a trailblazing clinical-stage biotech company...
A groundbreaking advancement in the realm of targeted drug delivery has emerged from the laboratories of The Grainger College of...
In recent years, the biomedical research community has witnessed transformative advancements in human stem cell-derived disease models, heralding a new...
A groundbreaking study published in the esteemed journal Aging Cell unveils a revolutionary approach to drug discovery that could redefine...
In a groundbreaking advancement in the field of pharmacology and computational biology, researchers have unveiled a transformative approach to systematically...
In a groundbreaking development poised to revolutionize treatment strategies for inflammatory bowel disease (IBD), researchers at the University of British...
The Icahn School of Medicine at Mount Sinai has embarked on a transformative venture with the launch of its AI...
In the realm of modern chemistry and drug development, the innovative field of biomimetic synthesis has emerged as a pivotal...
A groundbreaking study published in Nature Communications reveals the immense potential of computer algorithms in the quest for new anti-inflammatory...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine